Open Access<p>Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis</p>
Author(s) -
Valentina Perrone,
Luca Degli Esposti,
Elisa Giacomini,
Chiara Veronesi,
V Blini,
Marco Oderda
Publication year - 2020
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s249208
Subject(s) - medicine , prostate cancer , cohort , androgen deprivation therapy , incidence (geometry) , myocardial infarction , agonist , hazard ratio , proportional hazards model , retrospective cohort study , endocrinology , cancer , oncology , receptor , confidence interval , physics , optics
To evaluate and compare the incidence of cardiovascular (CV) events in a large contemporary cohort of patients diagnosed with prostate cancer (PCa) and in treatment with GnRH agonists or GnRH antagonists.